Dihydroorotate Dehydrogenase as a Target for the Development of Novel Helicobacter pylori-Specific Antimicrobials

Chemical & Pharmaceutical Bulletin
Tomokazu OhishiManabu Kawada

Abstract

Helicobacter pylori (H. pylori) infection is the world's most common bacterial infection, affecting approximately 50% of the global population. H. pylori is the strongest known risk factor for stomach diseases, including cancer. Hence, treatment for H. pylori infection can help reduce the risk of these diseases. However, the emergence of drug-resistant strains of H. pylori and the occurrence of adverse effects resulting from current therapies have complicated the successful eradication of H. pylori infection. Although various antibiotics that target several bacterial enzymes have been discovered, dihydroorotate dehydrogenase (DHODH) may hold potential for the development of novel anti-H. pylori agents with reduced toxicity and side effects. Here we review the existing literature that has focused on strategies for developing novel therapeutic agents that target the DHODH of H. pylori.

References

Dec 1, 1994·The Journal of Applied Bacteriology·G L MendzW J O'Sullivan
Oct 23, 1997·Clinical Microbiology Reviews·B E DunnM J Blaser
May 21, 1999·Science·A CovacciR Rappuoli
Aug 12, 2000·The Journal of Biological Chemistry·R A CopelandF Hobbs
Mar 21, 2002·Nature Reviews. Cancer·Richard M Peek, Martin J Blaser
Oct 4, 2002·Journal of Medicinal Chemistry·Tasir S HaqueAndrew P Combs
Oct 9, 2002·Nature·Malcolm J GardnerBart Barrell
Apr 21, 2004·The Journal of Biological Chemistry·David R Evans, Hedeel I Guy
Dec 10, 2008·The New England Journal of Medicine·Harald NoedlUNKNOWN Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium
Jul 31, 2009·The New England Journal of Medicine·Arjen M DondorpNicholas J White
Mar 5, 2013·Journal of Medicinal Chemistry·Hélène Munier-LehmannYves L Janin
Jul 17, 2015·Science Translational Medicine·Margaret A PhillipsSusan A Charman
Sep 29, 2015·World Journal of Methodology·Reza GhotaslouYalda Mohammadzadeh Asl
Oct 23, 2016·Lancet·Jyh-Ming LiouUNKNOWN Taiwan Gastrointestinal Disease and Helicobacter Consortium

❮ Previous
Next ❯

Citations

Dec 19, 2019·Pharmaceutics·Andrés GonzálezÁngel Lanas
Sep 27, 2019·European Journal of Medicinal Chemistry·Donatella BoschiMarco L Lolli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.